FOXO1 and cancer: In a meta-analysis, miR-27a was showed as a new potential FoxO1 regulator during muscle wasting in cancer cachexia; miR-27a inhibits the expression of FoxO1, so as to inhibit muscle atrophy (Freire et al., 2019).